Robert B Rothermel - Net Worth and Insider Trading

Robert B Rothermel Net Worth

The estimated net worth of Robert B Rothermel is at least $0 dollars as of 2024-12-14. Robert B Rothermel is the Director of DMK Pharmaceuticals Corp and owns about 1,907 shares of DMK Pharmaceuticals Corp (DMKPQ) stock worth over $0. Details can be seen in Robert B Rothermel's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert B Rothermel has not made any transactions after 2019-05-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Robert B Rothermel

To

Robert B Rothermel Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Robert B Rothermel owns 1 companies in total, including DMK Pharmaceuticals Corp (DMKPQ) .

Click here to see the complete history of Robert B Rothermel’s form 4 insider trades.

Insider Ownership Summary of Robert B Rothermel

Ticker Comapny Transaction Date Type of Owner
DMKPQ DMK Pharmaceuticals Corp 2019-05-24 director

Robert B Rothermel Latest Holdings Summary

Robert B Rothermel currently owns a total of 1 stock. Robert B Rothermel owns 1,907 shares of DMK Pharmaceuticals Corp (DMKPQ) as of May 24, 2019, with a value of $0.

Latest Holdings of Robert B Rothermel

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
DMKPQ DMK Pharmaceuticals Corp 2019-05-24 1,907 0.00 0

Holding Weightings of Robert B Rothermel


Robert B Rothermel Form 4 Trading Tracker

According to the SEC Form 4 filings, Robert B Rothermel has made a total of 0 transactions in DMK Pharmaceuticals Corp (DMKPQ) over the past 5 years. The most-recent trade in DMK Pharmaceuticals Corp is the acquisition of 93 shares on May 24, 2019, which cost Robert B Rothermel around $10,270.

Insider Trading History of Robert B Rothermel

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Robert B Rothermel Trading Performance

GuruFocus tracks the stock performance after each of Robert B Rothermel's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robert B Rothermel is -7.16%. GuruFocus also compares Robert B Rothermel's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robert B Rothermel within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Robert B Rothermel's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Robert B Rothermel

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 5.04 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 6.24 LIMIT LIMIT LIMIT LIMIT LIMIT

Robert B Rothermel Ownership Network

Ownership Network List of Robert B Rothermel

No Data

Ownership Network Relation of Robert B Rothermel

Insider Network Chart

Robert B Rothermel Owned Company Details

What does DMK Pharmaceuticals Corp do?

Who are the key executives at DMK Pharmaceuticals Corp?

Robert B Rothermel is the director of DMK Pharmaceuticals Corp. Other key executives at DMK Pharmaceuticals Corp include General Counsel Dorbin John W. Jr. , CFO Seth Cohen , and director & CEO Ebrahim Versi .

DMK Pharmaceuticals Corp (DMKPQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of DMK Pharmaceuticals Corp (DMKPQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of DMK Pharmaceuticals Corp (DMKPQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

DMK Pharmaceuticals Corp (DMKPQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

DMK Pharmaceuticals Corp Insider Transactions

No Available Data

Robert B Rothermel Mailing Address

Above is the net worth, insider trading, and ownership report for Robert B Rothermel. You might contact Robert B Rothermel via mailing address: 828 Balmoral Ln, Northbrook Il 60062.